Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibopamine challenge in progressive versus stable primary open-angle glaucoma
ACTRN12611001191987Phase 4Completed
- Sponsor
- John Landers
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Ibopamine in Glaucoma and open-angle glaucoma (OAG) (2 arms), sponsored by John Landers. Primary endpoint: Positive Ibopamine challenge proportion. Started Jul 2012; status: completed.
02
Drugs
Ibopamine
03
Conditions
Glaucomaopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on ACTRN12611001191987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001191987.